Follow-up for death or recurrence is not a reliable way of assessing the accuracy of diagnostic tests for thromboembolic disease.
Egermayer
P
P
Canterbury Respiratory Research Group, Christchurch, New Zealand.
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D002423:Cause of Death; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D010919:Placebos; D011237:Predictive Value of Tests; D011655:Pulmonary Embolism / Q000517:prevention & control; D012008:Recurrence; D015203:Reproducibility of Results; D012307:Risk Factors; D013923:Thromboembolism / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control / Q000601:surgery; D014680:Veins / Q000601:surgery; D016306:Vena Cava Filters
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010919:Placebos